Languages Available
 
C

PT. Indofarma (Persero) Tbk [INAF]   IDR 3.370  -150 (-4,26%)


Loading...
INAF IDR 3.370  -150 (-4,26%)
Last Update 11 December 2017 04:00 PM
Open
IDR 3.520
Prev Close
IDR 3.520
Offer
IDR 3.380
Bid
IDR 3.280
Day Low
IDR 3.250
Day High
IDR 3.530
Volume
6.505 Lots (650.500 Shares)
Value (IDR)
2.188,70 M
Frequency
414 (Times)
EPS (IDR)
-34,55
PE Ratio (ttm)
-101,88 %
Market Cap. (IDR)
10.443.630,00 M
Market Cap. Rank in Industry
#3 of 11 Companies in Pharmaceuticals
Market Cap. Rank in All Companies
#93 of 581 Companies
F
Net Foreign

This section of IDNFinancials requires you to sign up as a premium member of IDNFinancials.

Please check our pricing page to see all of our features.
O
Overview


PT. Indofarma (Persero) Tbk (INAF) is a manufacturer of drug, which consists of several product categories, namely Unbranded Generic or OTC Over the Counter (OTC), branded generic, rapid diagnostic test, and others. In addition, it also produces packaging materials, machinery, equipment and infrastructure related to pharmaceutical and other industries. The company commenced its commercial operations and production on 1983. The company’s products are marketed both domestically and internationally.

 

Source: www.indofarma.co.id

Subsidiary Affiliation
 
Company Name
Percentage
1.
PT. Indofarma Global Medika
99,99 %
G
Management
Commissioners
-
President Commissioner
Commissioner
Independent Commissioner
Teddy Wibisana
Directors
-
President Director
Rusdi Rosman
Director
Director
Wahyuli Syafari
Graph goes here...
S
Shareholders
No. Shareholder Name Number of Shares Total Paidup Capital Percentage
1. (Serie B) - Goverment of The Republic of Indonesia 2.499.999.999 IDR 249.999.999.900 80,66 %
2. (Serie B) - Public (each below 5%) 399.271.000 IDR 39.927.100.000 12,88 %
3. (Serie B) - PT. ASABRI (Persero) 199.996.500 IDR 19.999.650.000 6,45 %
4. (Serie A) - Goverment of The Republic of Indonesia (Dwiwarna) 1 IDR 100 3e-10 %
V
Videos
IDNFinancials Video - Company profile PT Indofarma Tbk
10 January 2013 09:02 AM
Company profile PT Indofarma Tbk
S
News Update
10 August 2015 11:04 AM Indofarma Targets 15-20% Margin Growth yosefardi.biz
09 September 2015 04:43 PM Siti Fadilah testifies medical equipments case trial yosefardi.biz
A
Announcement
Indofarma (Persero) will hold annual shareholders' meeting on April 20, 2017
2017-03-10 11:00:02
Links: [1]
Indofarma will hold annual shareholders' meeting on April 6, 2016
2016-02-22 23:05:27
Links: [1] [2]
S
Financial